Finance

Lists
603566:SHA
Pulike Biological Engineering Inc
CN¥10,05
-1,37%
(-0,14) 1D
15 Okt., 15:00:00 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603566...
Open
CN¥10,04
High
CN¥10,13
Low
CN¥9,99
Mkt. cap
3,55 mjd
Avg. vol.
2,55 m
Volume
3,56 m
Dividend
5,97%
Quarterly dividend
CN¥0,15
Ex-dividend date
16 Jun. 2026
P/E ratio
23,34
52-wk high
CN¥14,58
52-wk low
CN¥9,56
EPS
CN¥0,43
Shares outstanding
323,74 m
No. of employees
2 k
Open
CN¥10,04
High
CN¥10,13
Low
CN¥9,99
Mkt. cap
3,55 mjd
Avg. vol.
2,55 m
Volume
3,56 m
Dividend
5,97%
Quarterly dividend
CN¥0,15
Ex-dividend date
16 Jun. 2026
P/E ratio
23,34
52-wk high
CN¥14,58
52-wk low
CN¥9,56
EPS
CN¥0,43
Shares outstanding
323,74 m
No. of employees
2 k
News stories
From web sources and news partners
About Pulike Biological Engineering Inc
CEO-
Employees1,52 k
Founded1995
Headquarters-
SectorPharmaceutical industry
Websitepulike.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
263,58 m
266,87 m
249,24 m
242,03 m
Cost of goods sold
100,95 m
111,89 m
112,42 m
105,17 m
Cost of revenue
100,95 m
111,89 m
112,42 m
105,17 m
Research and development expenses
23,68 m
32,28 m
20,02 m
31,43 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95,68 m
103,92 m
71,24 m
76,01 m
Operating expense
124,41 m
142,59 m
97,95 m
117,02 m
Total operating expenses
225,35 m
254,48 m
210,37 m
222,20 m
Operating income
38,23 m
12,39 m
38,87 m
19,83 m
Other non operating income
688,80 k
-993,07 k
-144,35 k
-284,28 k
EBT including unusual items
45,54 m
30,98 m
45,02 m
28,40 m
EBT excluding unusual items
38,42 m
15,98 m
40,06 m
23,95 m
Income tax expense
4,58 m
3,13 m
9,36 m
185,73 k
Effective tax rate
10,06%
10,09%
20,80%
0,65%
Other operating expenses
4,26 m
3,33 m
4,62 m
3,65 m
Net income
40,95 m
27,86 m
40,73 m
36,59 m
Net profit margin
15,54%
10,44%
16,34%
15,12%
Earnings per share
-
-
-
-
Interest and investment income
-
4,96 m
1,54 m
5,30 m
Interest expense
-666,87 k
-59,75 k
-201,53 k
-105,64 k
Net interest expenses
-666,87 k
4,90 m
1,34 m
5,20 m
Depreciation and amortization charges
-
-
-
-
EBITDA
68,04 m
42,42 m
68,89 m
58,02 m
Gain or loss from assets sale
-599,30 k
630,42 k
-
-33,88 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme